Listen now (34 mins) | After heart disease cancer is the leading cause of mortality in the US at over 600,000 deaths annually. Not surprisingly cancer care costs are considerable at approximately $210 billion of which approximately 10% is paid out of pocket. This explains why in part up to 30% of Medicare beneficiaries without subsidies do not fill their anticancer prescriptions. To make matters worse, the COVID pandemic has significantly compromised cancer diagnosis and treatment that are expected to produce negative ripple effects. While President Biden’s “Cancer Moonshot,” aims to cut cancer death rates by 50% over the next 25 years, last year the CDC projected that because of the growth and aging of the population the annual number of cancer cases will increase nearly 50% between 2015 and 2050.
Patricia Goldsmith Discusses CancerCare (October 5th)
Patricia Goldsmith Discusses CancerCare…
Patricia Goldsmith Discusses CancerCare (October 5th)
Listen now (34 mins) | After heart disease cancer is the leading cause of mortality in the US at over 600,000 deaths annually. Not surprisingly cancer care costs are considerable at approximately $210 billion of which approximately 10% is paid out of pocket. This explains why in part up to 30% of Medicare beneficiaries without subsidies do not fill their anticancer prescriptions. To make matters worse, the COVID pandemic has significantly compromised cancer diagnosis and treatment that are expected to produce negative ripple effects. While President Biden’s “Cancer Moonshot,” aims to cut cancer death rates by 50% over the next 25 years, last year the CDC projected that because of the growth and aging of the population the annual number of cancer cases will increase nearly 50% between 2015 and 2050.